GR3003749T3 - - Google Patents

Info

Publication number
GR3003749T3
GR3003749T3 GR910401848T GR910401848T GR3003749T3 GR 3003749 T3 GR3003749 T3 GR 3003749T3 GR 910401848 T GR910401848 T GR 910401848T GR 910401848 T GR910401848 T GR 910401848T GR 3003749 T3 GR3003749 T3 GR 3003749T3
Authority
GR
Greece
Prior art keywords
pgfs
blood pressure
vassopressors
ephemeral
trachea
Prior art date
Application number
GR910401848T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003749T3 publication Critical patent/GR3003749T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
GR910401848T 1987-04-30 1992-02-10 GR3003749T3 (en, 2012)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10752987 1987-04-30
JP23589087 1987-09-18

Publications (1)

Publication Number Publication Date
GR3003749T3 true GR3003749T3 (en, 2012) 1993-03-16

Family

ID=26447552

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910401848T GR3003749T3 (en, 2012) 1987-04-30 1992-02-10

Country Status (11)

Country Link
US (1) US5106869A (en, 2012)
EP (1) EP0289349B1 (en, 2012)
JP (1) JPH0667900B2 (en, 2012)
KR (1) KR930006202B1 (en, 2012)
AT (1) ATE72235T1 (en, 2012)
CA (1) CA1324129C (en, 2012)
DE (2) DE3868127D1 (en, 2012)
ES (1) ES2032016T3 (en, 2012)
GR (1) GR3003749T3 (en, 2012)
NL (1) NL300135I2 (en, 2012)
ZA (1) ZA886909B (en, 2012)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化
DE68929563D1 (de) * 1988-09-06 2009-03-05 Pfizer Health Ab Prostaglandin-Derivate zur Behandlung von Glaukom und ocularer Hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE69019431T2 (de) * 1989-07-27 1995-09-14 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
DE69018903T2 (de) * 1989-08-09 1995-08-24 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
TW224942B (en, 2012) * 1990-04-04 1994-06-11 Adka Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
US5221690A (en) * 1991-10-02 1993-06-22 R-Tech Ueno Ltd. Increasing the choroidal blood flow
ATE153855T1 (de) * 1992-10-13 1997-06-15 Alcon Lab Inc Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
CN1269784A (zh) * 1997-09-09 2000-10-11 普罗克特和甘保尔公司 用作fp激活剂的芳香族c16-c20-取代四氢前列腺素
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
WO2001046134A1 (en) * 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
EP2314299A1 (en) * 2002-08-29 2011-04-27 Santen Pharmaceutical Co., Ltd Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
ES2431640T3 (es) 2003-08-21 2013-11-27 Sucampo Ag Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad
WO2005044276A1 (ja) 2003-11-07 2005-05-19 Senju Pharmaceutical Co., Ltd. プロスタグランジン含有医薬組成物
EP1830793A1 (en) * 2004-12-29 2007-09-12 R-Tech Ueno, Ltd. Composition and method for scalp and hair treatment
WO2007086536A2 (en) 2006-01-24 2007-08-02 R-Tech Ueno, Ltd. Soft-gelatin capsule formulation
CN104224704A (zh) * 2006-03-13 2014-12-24 株式会社·R-技术上野 水性组合物
EP2694077A4 (en) 2011-04-07 2015-01-21 Sucampo Ag METHOD FOR TREATING ASTHENOPY
SG10201606442QA (en) 2011-08-05 2016-09-29 Sucampo Ag Method for treating schizophrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
JP6162646B2 (ja) * 2014-05-27 2017-07-12 信越化学工業株式会社 3,5−ジメチルドデカン酸の製造方法
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505386A (en) * 1965-12-29 1970-04-07 Upjohn Co Compounds related to prostaglandins
US3984455A (en) 1973-07-16 1976-10-05 The Upjohn Company Prostaglandin E1 analogs
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ardsおよび多器官不全治療、予防におけるプロスタグランジンの使用
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
FR2613722B1 (fr) * 1987-04-07 1990-11-23 Bp Chimie Sa Procede de fabrication de granules d'homopolymere ou de copolymere de propylene

Also Published As

Publication number Publication date
DE10399038I2 (de) 2004-09-23
KR880012540A (ko) 1988-11-28
JPH01151552A (ja) 1989-06-14
NL300135I1 (nl) 2003-12-01
CA1324129C (en) 1993-11-09
DE10399038I1 (de) 2004-05-06
JPH0667900B2 (ja) 1994-08-31
ATE72235T1 (de) 1992-02-15
ZA886909B (en) 1989-05-30
ES2032016T3 (es) 1993-01-01
DE3868127D1 (de) 1992-03-12
NL300135I2 (nl) 2004-05-03
EP0289349A1 (en) 1988-11-02
KR930006202B1 (ko) 1993-07-08
EP0289349B1 (en) 1992-01-29
US5106869A (en) 1992-04-21

Similar Documents

Publication Publication Date Title
GR3003749T3 (en, 2012)
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
ZA908953B (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
DE3883551D1 (de) Druckausbalancierte Dichtung mit "S" Querschnitt.
MY106705A (en) Composites and methods for making same.
CA1251462C (en, 2012)
IT8422916A0 (it) Procedimento per la produzione dicorpi carboniosi.
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0183538A3 (en) 2,2' -isopropylidine bis (tetrahydrofuran) and method of preparation
AU3660284A (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
CA2001782A1 (en) 3-(3-propan-2-ylphenyl) butanal and 3-(3-propen-2-ylphenyl) butanal and their use as odorants
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
GR3004866T3 (en, 2012)
GR3005231T3 (en, 2012)
FI851969A7 (fi) Korkean verenpaineen hoitoon soveltuvia tetrahydronaftalenoleja.
IT8422915A0 (it) Procedimento per la produzione dicorpi carboniosi.
IT8821003A0 (it) Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/ 4 (idrossidifenilmetil) 1piperidinbutanolo".
ZA868116B (en) 5-heterocyclic-2,4-dialkyl-3h-1.2.4-triazole-3-thiones and their use as antidepressants
SU1216944A1 (ru) Способ получения 2,6-ди-трет-бутилфенола
IT8520633A0 (it) Procedimento per la preparazione della 1-(4,6-bis-allilammino-s-triazinil)-4-(p,p'-difluorobenzidril)piperazi na.
SU1269465A1 (ru) Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов
IE870825L (en) 1,4-diazepines.